Circulating microRNAs Signature for Predicting Response to GLP1-RA Therapy in Type 2 Diabetic Patients: A Pilot Study.

Int J Mol Sci · 2021 · PMC8431190 · PMID 34502360

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

marginally significantp = 0.06so close (0.05 < p ≤ 0.1)

A repeated measures one-way ANOVA was performed to compare the effect of GLP1-RA treatment on several efficacy measures over time, revealing that there was a statistically significant difference in mean HbA1c ( p = 0.003), BW ( p = 0.0013) and BMI ( p = 0.0015) between at least two groups, and a marginally significant difference in FPG ( p = 0.06).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.